Medulloblastoma is a heterogeneous central nervous system tumor stratified into four molecular subgroups in the revised 2021 WHO classification. Although MRI remains essential for follow-up, distinguishing true recurrence from treatment-related changes can be ... ...

请注册登录后继续浏览